AU2213197A - Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor - Google Patents
Combinational therapeutic methods employing nitric oxide scavengers and compositions useful thereforInfo
- Publication number
- AU2213197A AU2213197A AU22131/97A AU2213197A AU2213197A AU 2213197 A AU2213197 A AU 2213197A AU 22131/97 A AU22131/97 A AU 22131/97A AU 2213197 A AU2213197 A AU 2213197A AU 2213197 A AU2213197 A AU 2213197A
- Authority
- AU
- Australia
- Prior art keywords
- nitric oxide
- therapeutic methods
- compositions useful
- methods employing
- useful therefor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1282096P | 1996-03-05 | 1996-03-05 | |
US60012820 | 1996-03-05 | ||
PCT/US1997/004131 WO1997032585A1 (en) | 1996-03-05 | 1997-03-05 | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU69984/98A Division AU722361B2 (en) | 1995-11-21 | 1998-06-09 | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2213197A true AU2213197A (en) | 1997-09-22 |
Family
ID=21756859
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU22131/97A Abandoned AU2213197A (en) | 1996-03-05 | 1997-03-05 | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2000506170A (en) |
AU (1) | AU2213197A (en) |
CA (1) | CA2238029A1 (en) |
WO (1) | WO1997032585A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0835659T3 (en) * | 1996-10-14 | 2005-04-18 | Aventis Pharma Gmbh | Use of non-peptidic antagonists for bradykinin in the manufacture of drugs for the treatment and prevention of Alzheimer's disease |
WO1999051215A2 (en) * | 1998-04-06 | 1999-10-14 | Fujisawa Pharmaceutical Co., Ltd. | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
ATE333447T1 (en) * | 1998-06-01 | 2006-08-15 | Shionogi & Co | CYANOIMINOCHINOXALINE DERIVATIVES |
US6093743A (en) | 1998-06-23 | 2000-07-25 | Medinox Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
US6265420B1 (en) | 1998-06-23 | 2001-07-24 | Medinox, Inc. | Use of nitric oxide scavengers to treat side effects caused by therapeutic administration of sources of nitric oxide |
US6596770B2 (en) | 2000-05-05 | 2003-07-22 | Medinox, Inc. | Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor |
GB9903404D0 (en) * | 1999-02-16 | 1999-04-07 | Angiogene Pharm Ltd | Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis |
GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
US6274627B1 (en) | 1999-10-12 | 2001-08-14 | Medinox, Inc. | Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor |
US6271228B1 (en) * | 2000-04-28 | 2001-08-07 | Pfizer Inc. | Blood pressure stabilization during hemodialysis |
DE10230752A1 (en) * | 2002-07-09 | 2004-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New drug compositions based on magnesium salts and fibrinolytics |
EP1531825A2 (en) * | 2002-08-29 | 2005-05-25 | University Of Southampton | Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
WO2008038302A2 (en) * | 2006-09-26 | 2008-04-03 | Jegannathan Srinivas | Therapeutic formulation comprising a sulfonylurea, metformin and a nitric oxide scavenger. |
WO2009052376A1 (en) | 2007-10-18 | 2009-04-23 | Musc Foundation For Research Development | Methods for the diagnosis of genitourinary cancer |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5426046A (en) * | 1983-11-08 | 1995-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Human monoclonal antibody to lipid A of gram negative bacteria |
US5137889A (en) * | 1983-12-02 | 1992-08-11 | Otsuka Pharmaceutical Co., Ltd. | Dihydropyridine derivatives and process for preparing the same |
US4686100A (en) * | 1985-04-02 | 1987-08-11 | The Board Of Trustees Of The Leland Stanford Junior University | Method for the treatment of adult respiratory distress syndrome |
WO1989001772A1 (en) * | 1987-09-03 | 1989-03-09 | University Of Georgia Research Foundation, Inc. | Ocular cyclosporin composition |
US5294430A (en) * | 1988-09-12 | 1994-03-15 | University Of Rochester | Use of dithiocarbamates to treat myelosuppression |
US5176908A (en) * | 1988-12-19 | 1993-01-05 | American Cyanamid Company | Method for the treatment of endotoxic shock in mammal |
US5100899A (en) * | 1989-06-06 | 1992-03-31 | Roy Calne | Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof |
US5530141A (en) * | 1992-03-04 | 1996-06-25 | Center For Innovative Technology | 2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenase |
US5460954A (en) * | 1992-04-01 | 1995-10-24 | Cheil Foods & Chemicals, Inc. | Production of human proinsulin using a novel vector system |
AU3803593A (en) * | 1992-04-02 | 1993-11-08 | Smithkline Beecham Corporation | Compounds |
US5317040A (en) * | 1993-01-26 | 1994-05-31 | Washington University | Method for the treatment of pertussis with aminoguanidine |
US5436265A (en) * | 1993-11-12 | 1995-07-25 | Merck Frosst Canada, Inc. | 1-aroyl-3-indolyl alkanoic acids and derivatives thereof useful as anti-inflammatory agents |
-
1997
- 1997-03-05 AU AU22131/97A patent/AU2213197A/en not_active Abandoned
- 1997-03-05 WO PCT/US1997/004131 patent/WO1997032585A1/en active Application Filing
- 1997-03-05 CA CA002238029A patent/CA2238029A1/en not_active Abandoned
- 1997-03-05 JP JP9532042A patent/JP2000506170A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2000506170A (en) | 2000-05-23 |
WO1997032585A1 (en) | 1997-09-12 |
CA2238029A1 (en) | 1997-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7678496A (en) | Combinational therapeutic methods employing nitric oxide scavengers | |
AU7819994A (en) | Nitric oxide treatment | |
AU7323294A (en) | Perfluoroelastomeric compositions and methods | |
AU7564694A (en) | Erection-inducing methods and compositions | |
GB2310855B (en) | Substituted phenylbisacylphosphine oxides and photoinitiator mixtures | |
AU5565599A (en) | Chemically modified saponins and the use thereof as adjuvants | |
AU3691793A (en) | Gas well treatment compositions and methods | |
AUPM871994A0 (en) | Mini syringe and carry case | |
HK1045640A1 (en) | Novel use of nitric oxide | |
AU2349399A (en) | R-lansoprazole compositions and methods | |
AU2213197A (en) | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor | |
AU2972597A (en) | Compositions and uses thereof | |
AU8967998A (en) | Antibiotic-ligand conjugates and methods of use thereof | |
AU4215399A (en) | Dermatological compositions and methods | |
AU7401598A (en) | Epoxide-amine dendrimers and the preparation and use thereof | |
AU4006695A (en) | Calcineurin interacting protein compositions and methods | |
AU6528494A (en) | Nitric oxide combination therapy | |
IL127152A0 (en) | Methods of increasing nitric oxide synthesis | |
AU3674595A (en) | Antianemic agent containing iron and difructose | |
AU3200197A (en) | New composition and methods | |
AU8473398A (en) | 1,3-diaza- heterocycles and their use as nitric oxide synthase inhibitors | |
AU1829097A (en) | Methods for regenerating scarless skin and compositions used therein | |
AU6998498A (en) | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor | |
AU4018395A (en) | Compounding elements and use thereof | |
AU3868495A (en) | Acrolein-releasing composition and use thereof |